当前位置: X-MOL 学术Exp. Mol. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
IL-30† (IL-27A): a familiar stranger in immunity, inflammation, and cancer
Experimental & Molecular Medicine ( IF 9.5 ) Pub Date : 2021-05-28 , DOI: 10.1038/s12276-021-00630-x
Booki Min 1, 2 , Dongkyun Kim 1 , Matthias J Feige 3
Affiliation  

Over the years, interleukin (IL)-27 has received much attention because of its highly divergent, sometimes even opposing, functions in immunity. IL-30, the p28 subunit that forms IL-27 together with Ebi3 and is also known as IL-27p28 or IL-27A, has been considered a surrogate to represent IL-27. However, it was later discovered that IL-30 can form complexes with other protein subunits, potentially leading to overlapping or discrete functions. Furthermore, there is emerging evidence that IL-30 itself may perform immunomodulatory functions independent of Ebi3 or other binding partners and that IL-30 production is strongly associated with certain cancers in humans. In this review, we will discuss the biology of IL-30 and other IL-30-associated cytokines and their functions in inflammation and cancer.



中文翻译:

IL-30† (IL-27A):免疫、炎症和癌症领域的熟悉陌生人

多年来,白细胞介素 (IL)-27 因其在免疫中的高度不同,有时甚至是相反的功能而备受关注。IL-30 是与 Ebi3 一起形成 IL-27 的 p28 亚基,也称为 IL-27p28 或 IL-27A,被认为是代表 IL-27 的替代物。然而,后来发现 IL-30 可以与其他蛋白质亚基形成复合物,可能导致功能重叠或离散。此外,有新的证据表明,IL-30 本身可以发挥独立于 Ebi3 或其他结合伙伴的免疫调节功能,并且 IL-30 的产生与人类的某些癌症密切相关。在这篇综述中,我们将讨论 IL-30 和其他 IL-30 相关细胞因子的生物学及其在炎症和癌症中的功能。

更新日期:2021-05-28
down
wechat
bug